These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24452391)

  • 21. β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats.
    Hakami AY; Sari Y
    Neurosci Lett; 2017 Sep; 657():140-145. PubMed ID: 28826758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands.
    Knapp DJ; Overstreet DH; Breese GR
    Alcohol Clin Exp Res; 2005 Apr; 29(4):553-63. PubMed ID: 15834220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic postnatal stress induces voluntary alcohol intake and modifies glutamate transporters in adolescent rats.
    Odeon MM; Andreu M; Yamauchi L; Grosman M; Acosta GB
    Stress; 2015; 18(4):427-34. PubMed ID: 26037264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.
    Medrano MC; Mendiguren A; Pineda J
    Psychopharmacology (Berl); 2015 Aug; 232(15):2795-809. PubMed ID: 25787747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
    Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic alcohol consumption, withdrawal and nerve growth factor on neuropeptide Y expression and cholinergic innervation of the rat dentate hilus.
    Pereira PA; Rocha JP; Cardoso A; Vilela M; Sousa S; Madeira MD
    Neurotoxicology; 2016 May; 54():153-160. PubMed ID: 27090822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats.
    Kang S; Li J; Bekker A; Ye JH
    Neuropharmacology; 2018 Feb; 129():47-56. PubMed ID: 29128307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ceftriaxone on ethanol drinking and GLT-1 expression in ethanol dependence and relapse drinking.
    Griffin WC; Haun HL; Ramachandra VS; Knackstedt LA; Mulholland PJ; Becker HC
    Alcohol; 2021 May; 92():1-9. PubMed ID: 33465464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
    Uzbay T; Kayir H; Celik T; Yüksel N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats.
    Sari Y; Franklin KM; Alazizi A; Rao PS; Bell RL
    Neuroscience; 2013 Jun; 241():229-38. PubMed ID: 23537837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
    Dahchour A; De Witte P
    Alcohol; 1999 May; 18(1):77-81. PubMed ID: 10386669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of escitalopram on ethanol withdrawal syndrome in rats.
    Sağlam E; Kayir H; Celik T; Uzbay T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1027-32. PubMed ID: 16650516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome.
    Kaplan GB; Bharmal NH; Leite-Morris KA; Adams WR
    Alcohol; 1999 Oct; 19(2):157-62. PubMed ID: 10548160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal.
    Shirafuji S; Liu J; Okamura N; Hamada K; Fujimiya T
    Alcohol Clin Exp Res; 2010 Feb; 34(2):223-30. PubMed ID: 19951299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity.
    Hashimoto JG; Wiren KM
    Neuropsychopharmacology; 2008 Apr; 33(5):1084-96. PubMed ID: 17593928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further characterization of the GlyT-1 inhibitor Org25935: anti-alcohol, neurobehavioral, and gene expression effects.
    Lidö HH; Jonsson S; Hyytiä P; Ericson M; Söderpalm B
    J Neural Transm (Vienna); 2017 May; 124(5):607-619. PubMed ID: 28161754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanol-dependent rats.
    Dahchour A; De Witte P
    Pharmacol Biochem Behav; 2000 Feb; 65(2):345-50. PubMed ID: 10672989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of novel GLT-1 modulator, MC-100093, on neuroinflammatory and neurotrophic biomarkers in mesocorticolimbic brain regions of male alcohol preferring rats exposed chronically to ethanol.
    Travaglianti S; Alotaibi A; Wong W; Abou-Gharbia M; Childers W; Sari Y
    Brain Res Bull; 2024 Jun; 211():110935. PubMed ID: 38570076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.
    Vendruscolo LF; Barbier E; Schlosburg JE; Misra KK; Whitfield TW; Logrip ML; Rivier C; Repunte-Canonigo V; Zorrilla EP; Sanna PP; Heilig M; Koob GF
    J Neurosci; 2012 May; 32(22):7563-71. PubMed ID: 22649234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.